CT HB06727

Lowers the blood lead level thresholds triggering mandatory reporting, epidemiological investigations, and remediation orders on a phased schedule: ≥15 µg/dL through 2023, ≥10 µg/dL in 2024, and ≥5 µg/dL from January 1, 2025 onward.

Requires primary care providers, effective January 1, 2024, to conduct annual medical risk assessments for lead exposure for all children from birth to age six, mandatory lead screening at 12 and 24 months of age, and follow-up testing for children with confirmed blood lead levels ≥3.5 µg/dL.

Establishes new prenatal lead poisoning prevention requirements, directing prenatal health care providers to assess pregnant persons for lead exposure at the initial visit, screen or refer those at risk for blood lead testing, and notify local health directors if levels reach ≥3.5 µg/dL.

Reduces the notification deadline for providers to inform parents or guardians of a child under three with elevated blood lead results from 72 hours to 24 hours, and expands the educational outreach target for residential property owners from buildings built before 1950 to those built before 1978.

Designates the Department of Public Health as the lead state agency for lead poisoning prevention and control, requires annual reporting to legislative committees beginning October 1, 2023, mandates geographically indexed recordkeeping, and lowers the case management trigger for local health departments from 20 µg/dL to 3.5 µg/dL.